UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Thrombosis Outcomes in Pediatric Venous Thromboembolism

Completed

Conditions: Venous Thromboembolism

First Posted Date: 2017-03-03

Last Posted Date: 2025-01-31

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 120

Registration Number: NCT03068923

Locations: 🇺🇸
Children's Medical Center, Dallas, Texas, United States

Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer
Neoplasms, Oral
Neoplasms, Pharyngeal
Carcinoma, Squamous Cell

Interventions: Radiation: Intensity Modulated Radiation Therapy
Drug: chemotherapy

First Posted Date: 2017-03-01

Last Posted Date: 2022-03-17

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 72

Registration Number: NCT03067610

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)

Recruiting

Conditions: Brain Tumor Adult

Interventions: Drug: Hyperpolarized 13C-Pyruvate
Drug: Gadolinium

First Posted Date: 2017-03-01

Last Posted Date: 2025-03-06

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 25

Registration Number: NCT03067467

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Phase 2

Withdrawn

Conditions: Breast Cancer

Interventions: Drug: F-18 Fluoroestradiol
Procedure: Computed Tomography
Procedure: Positron Emission Tomography
Other: Laboratory Biomarker Analysis

First Posted Date: 2017-02-28

Last Posted Date: 2020-05-12

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT03065712

Locations: 🇺🇸
Clements University Hospital, Dallas, Texas, United States

SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients

Phase 2

Completed

Conditions: Kidney Cancer Metastatic
Kidney Cancer
Kidney Cancer, Stage IV

Interventions: Drug: Nivolumab/Ipilimumab
Radiation: SBRT

First Posted Date: 2017-02-27

Last Posted Date: 2021-03-30

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 29

Registration Number: NCT03065179

Locations: 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
UT Southwestern, Dallas, Texas, United States

Promoting Activity in Cancer Survivors

Not Applicable

Completed

Conditions: Physical Activity
Breast Cancer

Interventions: Behavioral: Physical activity education
Behavioral: Facility access
Behavioral: Supervised exercise sessions
Behavioral: Self-monitoring (Fitbit)
Behavioral: Active living counseling

First Posted Date: 2017-02-23

Last Posted Date: 2021-01-26

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 355

Registration Number: NCT03060941

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

UTSW HP [13-C] Pyruvate Injection in HCM

Completed

Conditions: Cardiomyopathy, Hypertrophic
Dilated Cardiomyopathy
Duchenne Muscular Dystrophy
Cardiac Sarcoidosis
Becker Muscular Dystrophy
Heart Failure with Preserved Ejection Fraction
Heart Failure with Reduced Ejection Fraction

Interventions: Diagnostic Test: Hyperpolarized 13C-Pyruvate

First Posted Date: 2017-02-17

Last Posted Date: 2025-03-26

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 7

Registration Number: NCT03057002

Locations: 🇺🇸
UT Southwestern Medical Center - Advanced Imaging Research Center, Dallas, Texas, United States

Breast Screening & Patient Navigation (BSPAN2): Evaluating a De-Centralized Regional Delivery System for Rural Underserved

Not Applicable

Completed

Conditions: Breast Cancer in Situ

Interventions: Behavioral: BSPAN

First Posted Date: 2017-02-14

Last Posted Date: 2018-04-23

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 18540

Registration Number: NCT03052907

Analysis of Neurocognitive Elements of Attention After Chemotherapy

Not Applicable

Completed

Conditions: Cancer Nos

Interventions: Other: Cognitive Assessment

First Posted Date: 2017-02-14

Last Posted Date: 2017-02-14

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 75

Registration Number: NCT03052868

Impact of Liraglutide 3.0 on Body Fat Distribution

Phase 4

Completed

Conditions: Obesity, Visceral
Cardiovascular Diseases
Fat Disorder

Interventions: Drug: Placebo
Drug: Liraglutide

First Posted Date: 2017-01-31

Last Posted Date: 2021-11-19

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 235

Registration Number: NCT03038620

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy